Estimating the costs of genomic sequencing in cancer control.

ABSTRACT:

Background

Despite the rapid uptake of genomic technologies within cancer care, few studies provide detailed information on the costs of sequencing across different applications. The objective of the study was to examine and categorise the complete costs involved in genomic sequencing for a range of applications within cancer settings.

Methods

We performed a cost-analysis using gross and micro-costing approaches for genomic sequencing performed during 2017/2018 across different settings in Brisbane, Australia. Sequencing was undertaken for patients with lung, breast, oesophageal cancers, melanoma or mesothelioma. Aggregated resource data were captured for a total of 1433 patients and point estimates of per patient costs were generated. Deterministic sensitivity analyses addr

SUBMITTER: Gordon LG 

PROVIDER: S-EPMC7268398 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature